IL129150A0 - 3-Carboxamide derivatives of 5H-pyrrolo (2,1-c) (1,4)-benzodiazepines - Google Patents

3-Carboxamide derivatives of 5H-pyrrolo (2,1-c) (1,4)-benzodiazepines

Info

Publication number
IL129150A0
IL129150A0 IL12915097A IL12915097A IL129150A0 IL 129150 A0 IL129150 A0 IL 129150A0 IL 12915097 A IL12915097 A IL 12915097A IL 12915097 A IL12915097 A IL 12915097A IL 129150 A0 IL129150 A0 IL 129150A0
Authority
IL
Israel
Prior art keywords
benzodiazepines
pyrrolo
carboxamide derivatives
carboxamide
derivatives
Prior art date
Application number
IL12915097A
Other languages
English (en)
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of IL129150A0 publication Critical patent/IL129150A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL12915097A 1996-11-01 1997-10-22 3-Carboxamide derivatives of 5H-pyrrolo (2,1-c) (1,4)-benzodiazepines IL129150A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74344396A 1996-11-01 1996-11-01
PCT/US1997/018918 WO1998020011A1 (en) 1996-11-01 1997-10-22 3-CARBOXAMIDE DERIVATIVES OF 5H-PYRROLO[2,1-c][1,4]-BENZODIAZEPINES

Publications (1)

Publication Number Publication Date
IL129150A0 true IL129150A0 (en) 2000-02-17

Family

ID=24988792

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12915097A IL129150A0 (en) 1996-11-01 1997-10-22 3-Carboxamide derivatives of 5H-pyrrolo (2,1-c) (1,4)-benzodiazepines

Country Status (19)

Country Link
EP (1) EP1021444B1 (xx)
JP (1) JP2001503759A (xx)
KR (1) KR20000052978A (xx)
CN (1) CN1330653C (xx)
AR (1) AR013329A1 (xx)
AT (1) ATE250607T1 (xx)
AU (1) AU737689B2 (xx)
BR (1) BR9713253A (xx)
CA (1) CA2268327C (xx)
DE (1) DE69725182T2 (xx)
DK (1) DK1021444T3 (xx)
ES (1) ES2206693T3 (xx)
HU (1) HUP9904514A3 (xx)
IL (1) IL129150A0 (xx)
NZ (1) NZ335483A (xx)
PT (1) PT1021444E (xx)
TW (1) TW496869B (xx)
WO (1) WO1998020011A1 (xx)
ZA (1) ZA979782B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001014336A1 (fr) * 1999-08-20 2001-03-01 Nippon Kayaku Kabushiki Kaisha Derives benzeniques substitues par un cycle aromatique, et leur procede de production
US6271418B1 (en) 2000-02-22 2001-08-07 Nippon Kayaku Co., Ltd. Process for preparing (hetero) aromatic substituted benzene derivatives
US6903087B2 (en) 2001-04-12 2005-06-07 Wyeth Pyrido cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
US6900200B2 (en) 2001-04-12 2005-05-31 Wyeth Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
US6977254B2 (en) 2001-04-12 2005-12-20 Wyeth Hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
US7202239B2 (en) 2001-04-12 2007-04-10 Wyeth Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists
US7109193B2 (en) 2001-04-12 2006-09-19 Wyeth Tricyclic diazepines tocolytic oxytocin receptor antagonists
US7064120B2 (en) * 2001-04-12 2006-06-20 Wyeth Tricyclic pyridyl carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
US7022699B2 (en) 2001-04-12 2006-04-04 Wyeth Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
US7326700B2 (en) 2001-04-12 2008-02-05 Wyeth Cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
GB0303852D0 (en) * 2003-02-19 2003-03-26 Pfizer Ltd Triazole compounds useful in therapy
EP1597260B1 (en) * 2003-02-19 2006-12-27 Pfizer Limited Triazole compounds useful in therapy
US7119088B2 (en) 2003-02-19 2006-10-10 Pfizer Inc. Triazole compounds useful in therapy
WO2009130232A1 (en) * 2008-04-24 2009-10-29 Glaxo Group Limited Pyrazolo [1, 5 -a] pyrazine derivatives as antagonists of v1b receptors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516774A (en) * 1993-07-29 1996-05-14 American Cyanamid Company Tricyclic diazepine vasopressin antagonists and oxytocin antagonists

Also Published As

Publication number Publication date
AU737689B2 (en) 2001-08-30
HUP9904514A3 (en) 2000-10-30
DE69725182T2 (de) 2004-06-24
HUP9904514A2 (hu) 2000-05-28
KR20000052978A (ko) 2000-08-25
ATE250607T1 (de) 2003-10-15
CN1330653C (zh) 2007-08-08
PT1021444E (pt) 2004-02-27
WO1998020011A1 (en) 1998-05-14
NZ335483A (en) 2001-09-28
ES2206693T3 (es) 2004-05-16
JP2001503759A (ja) 2001-03-21
CA2268327C (en) 2002-05-21
AR013329A1 (es) 2000-12-27
CA2268327A1 (en) 1998-05-14
EP1021444A1 (en) 2000-07-26
CN1234801A (zh) 1999-11-10
ZA979782B (en) 1999-04-30
AU4909797A (en) 1998-05-29
DK1021444T3 (da) 2004-01-19
TW496869B (en) 2002-08-01
DE69725182D1 (de) 2003-10-30
BR9713253A (pt) 1999-11-03
EP1021444B1 (en) 2003-09-24

Similar Documents

Publication Publication Date Title
GB2319250B (en) Derivatives of 6,8-Difluoro-7-Hydroxycoumarin
PL329875A1 (en) Derivatives of carbolin
PL329195A1 (en) Derivatives of 6-phenylpyridol-2-amine
IL125226A0 (en) Heterocycle-condensed morphinoid derivatives (II)
ZA9710906B (en) 6-Phenylpyridyl-2-amine derivatives
IL125379A (en) 19-nor-pregnene derivatives
PL329121A1 (en) Substituted derivatives of 1,2,3,4-tetrahydronaphtalene
HUP9902993A3 (en) Alkylaminobenzothiazole and -benzoxazole derivatives
IL129150A0 (en) 3-Carboxamide derivatives of 5H-pyrrolo (2,1-c) (1,4)-benzodiazepines
HUP9701835A3 (en) Vinyl-pirrolidinone-cephalosporin derivatives
IL129418A0 (en) 2-Methoxyphenylpiperazine derivatives
IL125149A0 (en) Pyrazol-4-yl-hetaroyl derivatives
PL334558A1 (en) Cephalosporinic derivatives
HU9701479D0 (en) N-benzylazolium derivatives
ZA972051B (en) Benzodiazonine derivatives
HUP9901875A3 (en) Isoxazolidine derivatives
GB9603226D0 (en) Heterocyclyl-ergoline derivatives
GB9600063D0 (en) Guaridine derivatives
ZA971911B (en) 2-thioxo-tetrahydropyrimidin-4-one derivatives
IL130283A0 (en) Polysaccharide-peptide derivatives
PL330141A1 (en) Novel derivatives of 10,11-dihydro-10-oxo-5h-dibezyl(b,f)-azepin-5-carboxagmide
GB9702049D0 (en) Tetrahhydroisoquinoline derivatives
HU9601036D0 (en) Aryl-sulfonyl-hydroxamic-acid derivatives
GB9622832D0 (en) Sordarin derivatives
GB9603581D0 (en) Amino-benzothiazole derivatives